A carregar...
Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is a rare, but aggressive endocrine malignancy with a generally poor clinical outcome. There is no effective therapy for advanced and metastatic ACC. In our study, we found that an existing drug (rottlerin) exerted its tumour-suppressive function in ACC. Specifically,...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410265/ https://ncbi.nlm.nih.gov/pubmed/28423559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15221 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|